A Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss

Simply Wall St.

04/11

AdvertisementWhy CONMED’s earnings surprise still pushed the stock lower CONMED (CNMD) reported Q4 revenue that came in 7.9% higher year over year and 1.7% ahead of expectations, yet the stock fell ...

网页链接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2626718142"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2626718142\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2626718142?lang=zh_TW&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-04-11 11:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626718142","market":"sg","top_or_hot":-1,"title":"A Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy CONMED’s earnings surprise still pushed the stock lower CONMED (CNMD) reported Q4 revenue that came in 7.9% higher year over year and 1.7% ahead of expectations, yet the stock fell ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnmd/conmed/news/a-look-at-conmeds-cnmd-valuation-after-mixed-q4-beat-and-ful\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Simply Wall St.</strong><span class=\"h-time small\">2026-04-11 11:31</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>AdvertisementWhy CONMED’s earnings surprise still pushed the stock lower CONMED (CNMD) reported Q4 revenue that came in 7.9% higher year over year and 1.7% ahead of expectations, yet the stock fell ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnmd/conmed/news/a-look-at-conmeds-cnmd-valuation-after-mixed-q4-beat-and-ful\">网页链接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnmd/conmed/news/a-look-at-conmeds-cnmd-valuation-after-mixed-q4-beat-and-ful\">Simply Wall St.</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0757428866.USD","symbol_name":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cnmd/conmed/news/a-look-at-conmeds-cnmd-valuation-after-mixed-q4-beat-and-ful","article_id":"2626718142","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cnmd/conmed/news/a-look-at-conmeds-cnmd-valuation-after-mixed-q4-beat-and-ful","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2626718142","pubTimestamp":1775878279,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why CONMED’s earnings surprise still pushed the stock lower\nCONMED (CNMD) reported Q4 revenue that came in 7.9% higher year over year and 1.7% ahead of expectations, yet the stock fell 4.5% after the company missed full-year EPS and revenue guidance.\nFor you as an investor, this mix of a quarterly revenue beat and weaker full-year delivery raises questions about how to weigh short-term execution against concerns about the company’s growth path and consistency.\nSee our latest analysis for...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","CNMD":"CONMED Corporation","LU1878469433.USD":"THREADNEEDLE (LUX) - AMERICAN SMALLER COMPANIES \"A\" (USD) ACC","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","BK4082":"医疗保健设备"},"translate_title":"在第四季度表现好坏参半和全年指引未达预期后，看看CONMED(CNMD)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNMD":1.5},"content_text":"AdvertisementWhy CONMED’s earnings surprise still pushed the stock lower CONMED (CNMD) reported Q4 revenue that came in 7.9% higher year over year and 1.7% ahead of expectations, yet the stock fell 4.5% after the company missed full-year EPS and revenue guidance. For you as an investor, this mix of a quarterly revenue beat and weaker full-year delivery raises questions about how to weigh short-term execution against concerns about the company’s growth path and consistency. See our latest analysis for CONMED. CONMED’s recent earnings reaction sits against a tougher share price picture, with a 5.61% 7 day share price return contrasting with a 9.33% year to date decline and a 28.45% 1 year total shareholder return loss, suggesting momentum has been fading. If this kind of volatility has you rethinking where to focus next, it may be worth scanning for other medical and surgical names using our dedicated screener for 31 healthcare AI stocks With CONMED trading at US$36.74 and data pointing to both an implied intrinsic discount and a gap to the average analyst price target, you now have to ask if this weakness signals an opportunity or if markets are already pricing in future growth. Most Popular Narrative: 24.1% Undervalued CONMED’s most followed narrative puts fair value at $48.40, meaning a meaningful gap to the last close at $36.74 that the market has not closed.  Enhanced R&D investment supporting proprietary product innovation, for example next-gen BioBrace and PlumeSafe PX5, paired with a strengthened balance sheet and declining leverage, provides CONMED with both pricing power and financial flexibility, boosting the potential for sustained improvements in net margins and long-term earnings resilience.  Read the complete narrative. Curious what earnings runway, margin profile, and future valuation multiple need to line up for that fair value to add up? The full narrative spells it out in detail. Result: Fair Value of $48.40 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still have to weigh supply chain setbacks and pressure on hospital capital budgets. These factors could challenge revenue consistency and the margin story behind that fair value. Find out about the key risks to this CONMED narrative. Next Steps With both risks and rewards on the table, do you feel the market reaction lines up with the full picture, or is sentiment off? Act while the facts are clear and shape your own view by weighing the 4 key rewards and 3 important warning signs. Looking for more investment ideas? If CONMED has sharpened your thinking, do not stop here. Use the Simply Wall Street Screener to spot other stocks that better match your goals and risk comfort.  Target potential mispricings by reviewing companies flagged in the 59 high quality undervalued stocks and see which ones deserve a closer look. Prioritize resilience by focusing on businesses highlighted in the 72 resilient stocks with low risk scores so sudden shocks do not catch you off guard. Hunt for early opportunities by scanning the screener containing 23 high quality undiscovered gems before they sit firmly on everyone else’s radar.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}